Skip to content
Screener

Eli Lilly LLY Q2 2026 earnings

Reported August 5, 2026 · Before market open

Revenue$23.0BBeat by $2.2B
EPS$8.38Beat by $1.98
Revenue estimate$20.8B
EPS estimate$6.40
“Lilly's momentum continues, as we delivered 48% revenue growth and raised our full-year guidance. At the same time, Lilly is building for the future. With our next-generation weight-loss medicine retatrutide and its complete clinical data package in hand, new manufacturing capacity coming online, and exciting new assets entering our pipeline through business development, Lilly's future, after 150 years, has never been brighter.”
David A. Ricks

Next report

Oct 29, 2026 (In 3 weeks)
Revenue estimate$22.3B
EPS estimate$9.92

Financials

Q2 2026

Income statement

See full
Revenue$23.0B+47.7%
Gross profit$19.7B+50.3%
Net income$7.1B+25.3%
EPS (diluted)$7.94+26.2%

Balance sheet

See full
Cash & equivalents$9.0B+165%
Total debt$54.9B+37.6%
Total equity$33.9B+85.4%
Total assets$142.28B+41.0%

Cash flow

See full
Operating cash flow$10.7B+246%
CapEx$2.9B+72.8%
Free cash flow$7.8B+458%

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$1.02T+39.5%
Enterprise value$1.07T+39.5%
P/E38.4×-1.5×
P/S12.9×+0.5×

Profitability

See full
Gross margin83.4%+0.8pp
Net margin33.5%+7.6pp
FCF margin22.8%+13.7pp

Returns & leverage

See full
Return on equity102.4%+15.7pp
Debt / equity1.6×-0.6×
Current ratio1.4×+0.1×

Segments

By product

See full
Mounjaro$9.9B+91.2%
Zepbound$4.9B+45.8%
Verzenio$1.5B-1.0%
Jardiance$1.2B+78.6%
Trulicity$1.2B+11.6%

By segment

See full
Reportable Segment$23.0B+47.7%

FAQ

When did Eli Lilly report Q2 2026 earnings?
Eli Lilly (LLY) reported Q2 2026 earnings on August 5, 2026 before market open.
What were Eli Lilly's Q2 2026 revenue and EPS?
Eli Lilly reported revenue of $23.0B and eps of $8.38 for Q2 2026.
Did Eli Lilly beat estimates in Q2 2026?
Revenue beat the consensus estimate of $20.8B by $2.2B. EPS beat the consensus estimate of $6.40 by $1.98.
How did Eli Lilly's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 47.7% from $15.6B a year earlier and eps grew 32.8% from $6.31.
Where can I find Eli Lilly's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000059478-26-000077) and the 10-Q periodic report (0000059478-26-000081) directly on SEC EDGAR. The filing index links above go to sec.gov.